Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
If you need longer support, your provider should reassess and adjust
Unpleasant taste: Capsules or flavored formulations may help mask the taste
Select on step 3 of the refill form
Lancet Oncol 15(6):569579 Thatcher N et al (2015) Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
Current studies mainly focus on combinations with dietary control, exercise, and other weightloss agents, aiming to enhance efficacy and reduce side effects
US$ 27.08
US$ 28.39
US$ 22.74
US$ 27.04
US$ 21.40
US$ 24.86
US$ 26.79
US$ 23.07
